Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Commission’s D’Acunto Tells EU Industry To Talk Less About Bottlenecks

Executive Summary

The medical technology industry has lobbied the European Commission hard because it believes the time it has to comply with the new Medical Device and IVD Regulations is much too short and threatens product availability. But the commission has hit back at these claims.

You may also be interested in...



MedTech Forum 2019: In The Medtech Glasshouse, Industry Need Not Fear Stones

Medtech’s contribution to health care improvements in Europe over the past 30 years has been a phenomenal journey of success – in patient terms as well as in commercial terms, says MedTech Europe chair Rob ten Hoedt. Local creativity has been able to mine a seam of product innovation that is unmatched anywhere in the world, but the sector is facing massive change and must find ways to cope.

How Europe’s Nomenclature System Works And Offers New Insights

Transparency linked to new device registration rules will provide new market analysis possibilities. Medtech Insight delved deeper into the benefits of the European Medical Device Nomenclature with two Italian executives who see its potential.

Reading Between The Lines: Is There A Positive Message Hidden In MDCG’s Blame Document?

The hope is now that a new EU document will be issued to address head on the scale of bottlenecks at notified bodies and of products needing to be removed from the market.

Topics

Latest News
UsernamePublicRestriction

Register

MT125219

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel